Citius Pharmaceuticals, Inc. 13D and 13G filings for Citius Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-16 4:34 pm Purchase |
2024-08-12 | 13D | Citius Oncology, Inc. CTOR |
Citius Pharmaceuticals Inc. CTXR |
66,049,615 92.600% |
66,049,615 (New Position) |
Filing |